Treatment of Pyoderma Gangrenosum With Bimekizumab
ABSTRACT Pyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis with no FDA‐approved treatments. Current therapies, including corticosteroids and immunomodulators, often show limited efficacy and nonspecific, conferring to higher risk of adverse events. We report a case of a 60‐year‐ol...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2025-12-01
|
| Edice: | JEADV Clinical Practice |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/jvc2.70052 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|